Literature DB >> 18758738

A circularly permuted beta-lactamase as a novel reporter for evaluation of protein cyclization efficiency.

Jeong Seon Kwon1, Jyotiranjan Bal, Hai Min Hwang, Jeong-Yoon Kim.   

Abstract

Split inteins have been used as a versatile tool in protein engineering to mediate efficient in vivo and in vitro trans-splicing of a protein. The trans-splicing ability of split inteins was also applied to the in vivo cyclization of a protein. However, cyclization efficiency is dependent upon the type of split inteins employed and the conditions under which cyclization occur. In this study, a novel reporter system that easily measures the cyclization efficiency of split inteins was developed. For this purpose TEM-1 beta-lactamase was divided into two fragments (24-215 and 216-286 amino acids) and circularly permuted. The circularly permuted beta-lactamase expressed in Escherichia coli showed little beta-lactamase activity, most likely due to the structural modification of the protein. However, when the circularly permuted beta-lactamase was cyclized by the Synechocystis sp. PCC6803 DnaB split mini-intein, beta-lactamase activity both in vitro and in vivo was recovered. These results suggest that the novel reporter system can be exploited to develop new inteins with high efficiency of in vivo protein cyclization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758738     DOI: 10.1007/s12275-008-0106-2

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  19 in total

1.  Circular beta-lactamase: stability enhancement by cyclizing the backbone.

Authors:  H Iwai; A Plückthun
Journal:  FEBS Lett       Date:  1999-10-08       Impact factor: 4.124

2.  Production of cyclic peptides and proteins in vivo.

Authors:  C P Scott; E Abel-Santos; M Wall; D C Wahnon; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 3.  Cyclic peptides, a chemical genetics tool for biologists.

Authors:  Alexander R Horswill; Stephen J Benkovic
Journal:  Cell Cycle       Date:  2005-04-05       Impact factor: 4.534

4.  Oxidative folding and N-terminal cyclization of onconase.

Authors:  Ervin Welker; Laura Hathaway; Guoqiang Xu; Mahesh Narayan; Lovy Pradeep; Hang-Cheol Shin; Harold A Scheraga
Journal:  Biochemistry       Date:  2007-04-18       Impact factor: 3.162

5.  Protein splicing in trans by purified N- and C-terminal fragments of the Mycobacterium tuberculosis RecA intein.

Authors:  K V Mills; B M Lew; S Jiang; H Paulus
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Protein trans-splicing and cyclization by a naturally split intein from the dnaE gene of Synechocystis species PCC6803.

Authors:  T C Evans; D Martin; R Kolly; D Panne; L Sun; I Ghosh; L Chen; J Benner; X Q Liu; M Q Xu
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Protein splicing elements: inteins and exteins--a definition of terms and recommended nomenclature.

Authors:  F B Perler; E O Davis; G E Dean; F S Gimble; W E Jack; N Neff; C J Noren; J Thorner; M Belfort
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

9.  Intein-mediated cyclization of a soluble and a membrane protein in vivo: function and stability.

Authors:  Christian Siebold; Bernhard Erni
Journal:  Biophys Chem       Date:  2002-05-02       Impact factor: 2.352

10.  Thermodynamic partitioning model for hydrophobic binding of polypeptides by GroEL. II. GroEL recognizes thermally unfolded mature beta-lactamase.

Authors:  R Zahn; A Plückthun
Journal:  J Mol Biol       Date:  1994-09-16       Impact factor: 5.469

View more
  1 in total

1.  Off-Pathway-Sensitive Protein-Splicing Screening Based on a Toxin/Antitoxin System.

Authors:  Hannes M Beyer; Hideo Iwaï
Journal:  Chembiochem       Date:  2019-07-03       Impact factor: 3.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.